Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium hydride | HCID 24758 | — |
| Reactant | 3-Cyclobutyl-2,3,4,5-tetrahydro-1H-benzo[D]azepin-7-OL | HCID 10082081 | — |
| Reactant | 1-(3-Chloropyrazin-2-yl)pyrrolidin-2-one | HCID 53249715 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 11740397 | HCID 11740397 | 48.3% |
Reaction Steps
3-Cyclobutyl-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-ol (E3) (103 mg, 0.47 mmol) was dissolved in dry dimethylformamide (3 ml), cooled to 0° C. and treated with sodium hydride (60% in mineral oil, 20 mg, 0.49 mmol). The mixture was allowed to warm to room temperature over 40 minutes. A solution of 1-(3-chloro-2-pyrazinyl)-2-pyrrolidinone (D46) (103 mg, 0.52 mmol) in dry dimethylformamide (1 ml) was added and the mixture stirred at room temperature for 2 hours and heated at 80° C. for 2.5 hours. The mixture was allowed to cool to room temperature and applied to a SCX column and washed with methanol then a mixture of 0.880 ammonia/methanol (1:9). The basic fractions were combined and concentrated in vacuo and resulting residue was purified by column chromatography eluting with a mixture of 0.880 ammonia:methanol:dichloromethane (0.2:1.8:98) to afford the title compound (86 mg); MS (ES+) m/e 379 [M+H]+.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07696193B2 |
|---|
| Source dataset | uspto-grants-2010_04 |
|---|
| ORD ID | ord-8ddf867300734a21b971a803d862fad3 |
|---|
| Source note | uspto-grants-2010_04 |
|---|